MedPath

Hospital General de México "Dr. Eduardo Liceaga"

🇲🇽Mexico
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

15

Active:0
Completed:6

Trial Phases

3 Phases

Phase 2:3
Phase 4:2
Not Applicable:8

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials

Not Applicable
8 (61.5%)
Phase 2
3 (23.1%)
Phase 4
2 (15.4%)

Types of Photoplethysmographic Waves in Adult Patients with Septic Shock

Recruiting
Conditions
Shock Septic
Photoplethysmography
Waveform
First Posted Date
2025-01-22
Last Posted Date
2025-01-22
Lead Sponsor
Hospital General de México Dr. Eduardo Liceaga
Target Recruit Count
116
Registration Number
NCT06786364
Locations
🇲🇽

Hospital General de México Dr. Eduardo Liceaga, Mexico city, Cuauhtemoc, Mexico

Orotracheal Intubation with the ORION Videolaryngoscope Versus the King Vision Videolaryngoscope in Adult Patients: ORION Trial

Not Applicable
Completed
Conditions
Orotracheal Intubation
Videolaryngoscopes (VL)
3D Printing
Anesthesia
First Posted Date
2024-10-02
Last Posted Date
2025-02-25
Lead Sponsor
Hospital General de México Dr. Eduardo Liceaga
Target Recruit Count
50
Registration Number
NCT06622538
Locations
🇲🇽

Hospital General de Mèxico Dr. Eduardo Liceaga, Mexico City, Cuauhtemoc, Mexico

Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole

Phase 4
Not yet recruiting
Conditions
Helicobacter Pylori Infection
Interventions
First Posted Date
2024-03-19
Last Posted Date
2024-03-19
Lead Sponsor
Hospital General de México Dr. Eduardo Liceaga
Target Recruit Count
160
Registration Number
NCT06318104

Clinical Trial Comparing the Self-test for Cervicovaginal Sample Versus Samples From Service Provider (Xyto-Ro)

Not Applicable
Conditions
Human Papillomavirus (HPV)-Related Cervical Cancer
HPV DNA
First Posted Date
2020-08-20
Last Posted Date
2020-08-20
Lead Sponsor
Hospital General de México Dr. Eduardo Liceaga
Target Recruit Count
444
Registration Number
NCT04520464
Locations
🇲🇽

Hospital General de México Eduardo Liceaga, Ciudad de mexico, Mexico

Anal Injury Screening for High Risk HPV

Not Applicable
Conditions
Anal Cancer
Anal Injury
First Posted Date
2020-08-13
Last Posted Date
2020-08-13
Lead Sponsor
Hospital General de México Dr. Eduardo Liceaga
Target Recruit Count
500
Registration Number
NCT04512508
Locations
🇲🇽

Hospital General de México Eduardo Liceaga, Ciudad de mexico, Mexico

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.